Pfizer requests expansion of COVID-19 vaccine emergency use authorization to include adolescents and young teens

Hospital News

Pfizer today said it is seeking an amended emergency use authorization for its COVID-19 vaccine, requesting that the Food and Drug Administration allow its use for individuals between 12 and 15 years old.

The request follows last week’s release of late-trial data affirming the vaccine’s safety for that age group, along with 100% effectiveness in preventing COVID-19.

Articles You May Like

April jobs report lackluster for healthcare, with ambulatory gains offsetting steep nursing losses
TAVR readmission rates vary widely between hospitals for unknown reasons
FEMA Advisory reminds groups of COVID-19 funding assistance available
Perspective: Inspiring Hope through Healing — Today, This Week and Everyday
Chair File: Gratitude — This Week and Every Week — for Our Hospital Teams